Association between HSV1 seropositivity and obesity: Data from the national health and nutritional examination survey, 2007-2008

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Karjala, Zuzana ^a   Neal, Diane ^a   Rohrer, James ^b  

^a WALDEN UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE PREDISPOSITION; EDUCATION; ETHNICITY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OBESITY; POVERTY; RACE DIFFERENCE; RISK FACTOR; SEROPREVALENCE; SEX DIFFERENCE; BLOOD; CROSS-SECTIONAL STUDY; ISOLATION AND PURIFICATION; NUTRITION; UNITED STATES;

SIMPLEXVIRUS;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; MALE; NUTRITION SURVEYS; OBESITY; UNITED STATES;

EID: 79955911802     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019092     Document Type: Article

References (40)

1. Center for Disease Control and Prevention (2010) Sexually transmitted disease surveillance 2007. Available:http://www.cdc.gov/STD/stats07/other.htm.
2. Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, et al. (2006) Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. Journal of American Medical Association 296 (8): 964-973 Available:http://jama.ama-assn.org/cgi/content/full/296/8/964.
3. Knezevic A, Martic J, Stanojevic M, Jankovic S, Nedeljkovic J, et al. (2007) Disseminated neonatal herpes caused by herpes simplex virus types 1 and 2. Emerging Infectious Diseases 13 (2): 302-304 Available:http://www.medscape.com/viewarticle/551399_2.
4. Fatahzadeh M, Schwartz RA, (2007) Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. Journal of American Academic Dermatology 57 (5): 737-763 doi:10.1016/j.jaad.2007.06.027.
5. Carr DJ, Tomanek L, (2006) Herpes simplex virus and the chemokines that mediate the inflammation. Current Topics in Microbiology and Immunology 303: 47-65 doi:10.1007/978-3-540-33397-5_3.
6. Kalimo KO, Joronen IA, Havu VK, (1983) Cell-mediated immunity against herpes simplex virus envelope, capsid, excreted, and crude antigens. Infection & Immunity 39 (1): 24-28 Available:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC347902/.
7. Sun Y, Pei W, Wu Y, Yang Y, (2005) An association of herpes simplex virus type I infection with type 2 diabetes. Diabetes Care 28 (2): 435-436 doi:10.2337/diacare.28.2.435.
8. Starr JR, Daling JR, Fitzgibbons ED, Madeleine MM, Ashley R, et al. (2001) Serologic evidence of herpes simplex virus 1 infection and oropharyngeal cancer risk. Cancer Research 61 (23): 8459-8464.
9. Szucs TD, Berger K, Fisman DN, Harbarth S, (2001) The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches. BMC Infectious Diseases 1: 5 doi:10.1186/1471-2334-1-5.
10. Smith JS, Bailey RC, Westreich DJ, Maclean I, Agot K, et al. (2009) Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing. Sexually Transmitted Infections 85 (2): 92-6 doi:10.1136/sti.2008.031815.
11. Schillinger JA, McKinney CM, Garg R, Gwynn RC, White K, et al. (2008) Seroprevalence of herpes simplex virus type 2 and characteristics associated with undiagnosed infection: New York City, 2004. Sexually Transmitted Diseases 35 (6): 599-606 doi:10.1097/OLQ.0b013e3181666fb1.
12. Peña KC, Adelson ME, Mordechai E, Blaho JA, (2010) Genital herpes simplex virus type 1 in Women: Detection in cervicovaginal specimens from gynecological practices in the United States. Journal of Clinical Microbiology 48 (1): 150-153 doi:10.1128/JCM.01336-09.
13. Roberts CM, Pfister JR, Spear SJ, (2003) Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sexually Transmitted Diseases 30 (10): 797-800.
14. Pebody RG, Andrews N, Brown D, Gopal R, De Melker H, et al. (2004) The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sexually Transmitted Infections 80 (3): 185-91.
15. Donoval BA, Passaro DJ, Klausner JD, (2006) The public health imperative for a neonatal herpes simplex virus infection surveillance system. Sexually Transmitted Diseases 33 (3): 170-174.
16. Krolczyk S, Pacheco E, Valencia P, Papazian O, Yelin K, et al. (2003) Opsoclonus: An early sign of neonatal herpes encephalitis. Journal of Child Neurology 18 (5): 356-358 doi:10.1177/08830738030180050201.
17. Kropp RY, Wong T, Cormier L, Ringrose A, Burton S, et al. (2006) Neonatal herpes simplex virus infections in Canada: Results of a 3-year national prospective study. Pediatrics 117 (6): 1955-1962 doi:10.1542/peds.2005-1778.
18. Hill J, Roberts S, (2005) Herpes Simplex Virus in Pregnancy: New concepts in prevention and management. Infectious Diseases in Pregnancy 32 (3): 657-670 doi:10.1016/j.clp.2005.05.008.
19. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, et al. (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. New England Journal of Medicine 355 (8): 763-778 doi:10.1056/NEJMoa055643.
20. Myles TD, Gooch J, Santolaya J, (2002) Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery. Obsterics and Gynecology 100 (5): 959-964 Available:http://www.ncbi.nlm.nih.gov/pubmed/12423861.
21. Fernandez-Real JM, Ferri MJ, Vendrell J, Ricart W, (2007) Burden of infection and fat mass in healthy middle-aged men. Obesity 15 (1): 245-52 doi:10.1038/oby.2007.541.
22. Trovato GM, Castro A, Tonzuso A, Garozzo A, Martines GF, et al. (2009) Human obesity relationship with Ad36 adenovirus and insulin resistance. International Journal of Obesity 33 (12): 1402-1409 doi:10.1038/ijo.2009.196.
23. Gabbert C, Donohue M, Arnold J, Schwimmer JB, (2010) Adenovirus 36 and obesity in children and adolescents. Pediatrics 126 (4): 721-726 doi:10.1542/peds.2009-3362.
24. Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, et al. (2005) Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. International Journal of Obesity (Lond) 29 (3): 281-286 doi:10.1038/sj.ijo.0802830.
25. Arslan E, Atilgan H, Yavaşoǧlu I, (2009) The prevalence of Helicobacter pylori in obese subjects. European Journal of Internal Medicine 20 (7): 695-697 doi:10.1016/j.ejim.2009.07.013.
26. Rantala A, Lajunen T, Juvonen R, Bloigu A, Paldanius M, et al. (2010) Chlamydia pneumoniae infection is associated with elevated body mass index in young men. Epidemiology and Infection 138 (9): 1267-1273 doi:10.1017/S0950268809991452.
27. Kopácová M, Bures J, Koupil I, Rejchrt S, Vorísek V, et al. (2007) Body indices and basic vital signs in Helicobacter pylori positive and negative persons. European Journal of Epidemiology 22 (1): 67-75 doi:10.1007/s10654-006-9090-1.
28. Center for Disease Control and Prevention (2009) NHANES 2007-2008 Public data general release file documentation. Available:http://www.cdc.gov/nchs/nhanes/nhanes2007-2008/generaldoc_e.htm.
29. StataCorp LP, (2010) Data Analysis and Software. Available:http://www.stata.com.
30. Lutsey PL, Pankow JS, Bertoni AG, Szklo M, Folsom AR, (2009) Serological evidence of infections and Type 2 diabetes: the MultiEthnic Study of Atherosclerosis. Diabetic Medicine 26 (2): 149-152 doi:10.1111/j.1464-5491.2008.02632.x.
31. Roivainen M, Viik-Kajander M, Palosuo T, Toivanen P, Leinonen M, et al. (2000) Infections, inflammation, and the risk of coronary heart disease. Circulation 101 (3): 252-257 Available:http://circ.ahajournals.org/cgi/content/full/101/3/252.
32. Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, et al. (2001) Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 104 (1): 25-31 doi:10.1161/hc2601.091703.
33. Falagas ME, Kompoti M, (2006) Obesity and infection. Lancet Infectious Diseases 6 (7): 438-446 Available:http://www.ncbi.nlm.nih.gov/pubmed/16790384.
34. Margetic S, Gazzola C, Pegg GG, Hill RA, (2002) Leptin: a review of its peripheral actions and interactions. International Journal of Obesity and Related Metabolic Disorders 26 (11): 1407-1433 doi:10.1038/sj.ijo.0802142.
35. Otero M, Lago R, Lago F, Casanueva FF, Dieguez C, et al. (2005) Leptin, from fat to inflammation: old questions and new insights. FEBS Letters 579 (2): 295-301 doi:10.1016/j.febslet.2004.11.024.
36. Bassols J, Moreno JM, Ortega F, Ricart W, Fernandez-Real JM, (2010) Characterization of herpes virus entry mediator as a factor linked to obesity. Obesity 18 (2): 239-46 doi:10.1038/oby.2009.250.
37. Meisinger C, Döring A, Thorand B, Heier M, Löwel H, (2006) Body fat distribution and risk of type 2 diabetes in the general population: are there differences between men and women? The MONICA/KORA Augsburg Cohort Study. American Journal of Clinical Nutrition 84 (3): 483-489 Available:http://www.ajcn.org/cgi/reprint/84/3/483.
38. Wellen KE, Hotamisligil GS, (2005) Inflammation, stress, and diabetes. Journal of Clinical Investigations 115 (5): 1111-1119 doi:10.1172/JCI25102.
39. Schwartz EJ, Bodine EN, Blower S, (2007) Effectiveness and efficiency of imperfect therapeutic HSV-2 vaccines. Human Vaccines 3 (6): 231-238 Available:http://www.ncbi.nlm.nih.gov/pubmed/17881889.
40. Wald A, Langenberg AG, Krantz E, Douglas JM Jr, Handsfield HH, et al. (2005) The relationship between condom use and herpes simplex virus acquisition. Annals of Internal Medicine 143 (10): 707-713 Available:http://www.annals.org/content/143/10/707.full.